Format

Send to

Choose Destination
Allergy. 2018 Jan;73(1):77-92. doi: 10.1111/all.13218. Epub 2017 Aug 24.

Transfer of innovation on allergic rhinitis and asthma multimorbidity in the elderly (MACVIA-ARIA) - EIP on AHA Twinning Reference Site (GARD research demonstration project).

Bousquet J1,2,3, Agache I4, Aliberti MR5, Angles R6, Annesi-Maesano I7,8, Anto JM9,10,11, Arnavielhe S12, Asayag E13, Bacci E14, Bedbrook A1, Bachert C15, Baroni I16, Barreto BA17, Bedolla-Barajas M18, Bergmann KC19,20, Bertorello L14, Bewick M21, Bieber T22, Birov S23, Bindslev-Jensen C24, Blua A25, Bochenska Marciniak M26, Bogus-Buczynska I26, Bosnic-Anticevich S27, Bosse I28, Bourret R29, Bucca C30, Buonaiuto R31, Burguete Cabanas MT32, Caillaud D33, Caimmi DP34, Caiazza D31, Camargos P35, Canfora G36, Cardona V37, Carriazo AM38, Cartier C39, Castellano G40, Chavannes NH41, Cecci L42, Ciaravolo MM43, Cingi C44, Ciceran A45, Colas L46, Colgan E47, Coll J6, Conforti D48, Correia de Sousa J49, Cortés-Grimaldo RM50, Corti F51, Costa E52, Courbis AL53, Cousein E54, Cruz AA55,56, Custovic A57, Cvetkovski B27, Dario C58, da Silva J59, Dauvilliers Y60, De Blay F61, Dedeu T62, De Feo G63, De Martino B64, Demoly P34, De Vries G65, Di Capua Ercolano S66, Di Carluccio N31, Doulapsi M67, Dray G53, Dubakiene R68, Eller E24, Emuzyte R69, Espinoza-Contreras JG70, Estrada-Cardona A71, Farrell J47, Farsi A42, Ferrero J72, Fokkens WJ73, Fonseca J74,75, Fontaine JF76, Forti S48, Gálvez-Romero JL77, García-Cobas CI78, Garcia Cruz MH79, Gemicioğlu B80, Gerth van Wijk R81, Guidacci M82, Gómez-Vera J83, Guldemond NA84, Gutter Z85, Haahtela T86, Hajjam J87, Hellings PW88, Hernández-Velázquez L89, Illario M90, Ivancevich JC91, Jares E92, Joos G93, Just J94,95, Kalayci O96, Kalyoncu AF97, Karjalainen J98, Keil T99, Khaltaev N100, Klimek L101, Kritikos V27, Kull I102, Kuna P26, Kvedariene V103, Kolek V104, Krzych-Fałta E105, Kupczyk M26, Lacwik P26, La Grutta S106, Larenas-Linnemann D107, Laune D12, Lauri D108, Lavrut J109, Lessa M110, Levato G111, Lewis L112, Lieten I113, Lipiec A105, Louis R114, Luna-Pech JA115, Magnan A46, Malva J116,117, Maspero JF118, Matta-Campos JJ119, Mayora O48, Medina-Ávalos MA120, Melén E121, Menditto E122, Millot-Keurinck J123, Moda G124, Morais-Almeida M125, Mösges R126, Mota-Pinto A117,127,128, Mullol J129, Muraro A130, Murray R131, Noguès M123, Nalin M16, Napoli L132, Neffen H133, O'Hehir RE134, Onorato GL1, Palkonen S135, Papadopoulos NG136,137, Passalacqua G138, Pépin JL139, Pereira AM140, Persico M141, Pfaar O142,101, Pozzi AC143, Prokopakis E67, Pugin B88, Raciborski F105, Rimmer J27, Rizzo JA144, Robalo-Cordeiro C145, Rodríguez-González M146, Rolla G124, Roller-Wirnsberger RE147, Romano A148,149, Romano M16, Romano MR5, Salimäki J150, Samolinski B105, Serpa FS151, Shamai S126, Sierra M6, Sova M152, Sorlini M153, Stellato C63, Stelmach R154, Strandberg T155, Stroetmann V23, Stukas R156, Szylling A105, Tan R27, Tibaldi V124, Todo-Bom A157, Toppila-Salmi S86, Tomazic P158, Trama U159, Triggiani M63, Valero A160, Valovirta E161,162, Valiulis A163,164, van Eerd M65, Vasankari T165, Vatrella A63, Ventura MT166, Verissimo MT116,117, Viart F39, Williams S167, Wagenmann M168, Wanscher C169, Westman M170, Wickman M121, Young I171, Yorgancioglu A172, Zernotti E173, Zuberbier T19,20, Zurkuhlen A174, De Oliviera B175, Senn A175.

Author information

1
MACVIA-France, Contre les MAladies Chroniques pour un VIeillissement Actif en France European Innovation Partnership on Active and Healthy Ageing Reference Site, Montpellier, France.
2
VIMA, INSERM U 1168, VIMA: Ageing and Chronic Diseases, Epidemiological and Public Health Approaches, Villejuif, France.
3
Université Versailles St-Quentin-en-Yvelines, UMR-S 1168, Montigny le Bretonneux, France.
4
Faculty of Medicine, Transylvania University, Brasov, Romania.
5
Municipality of Salerno, Salerno, Italy.
6
Innovación y nuevas tecnologías, Salud Sector sanitario de Barbastro, Barbastro, Spain.
7
EPAR U707 INSERM, Paris, France.
8
EPAR UMR-S UPMC, Paris VI, Paris, France.
9
ISGLoBAL, Centre for Research in Environmental Epidemiology (CREAL), Barcelona, Spain.
10
IMIM (Hospital del Mar Research Institute), Universitat Pompeu Fabra (UPF), Barcelona, Spain.
11
CIBER Epidemiología y Salud Pública (CIBERESP), Universitat Pompeu Fabra (UPF), Barcelona, Spain.
12
Kyomed, Montpellier, France.
13
Argentine Society of Allergy and Immunopathology, Buenos Aires, Argentina.
14
Regione Liguria, Genoa, Italy.
15
Upper Airways Research Laboratory, ENT Department, Ghent University Hospital, Ghent, Belgium.
16
Telbios SRL, Milan, Italy.
17
Alergologo, Belem, Brazil.
18
Hospital Civil de Guadalajara Dr. Juan I. Menchaca, Guadalarara, Mexico.
19
Comprehensive Allergy-Centre-Charité, Department of Dermatology and Allergy, Charité-Universitätsmedizin Berlin, Berlin, Germany.
20
Global Allergy and Asthma European Network (GA2LEN), Berlin, Germany.
21
iQ4U Consultants Ltd, London, UK.
22
Department of Dermatology and Allergy, Rheinische Friedrich-Wilhelms-University, Bonn, Germany.
23
Empirica Communication and Technology Research, Bonn, Germany.
24
Department of Dermatology and Allergy Centre, Odense University Hospital, Odense, Denmark.
25
Argentine Association of Respiratory Medicine, Buenos Aires, Argentina.
26
Division of Internal Medicine, Asthma and Allergy, Barlicki University Hospital, Medical University of Lodz, Lodz, Poland.
27
Woolcock Institute of Medical Research, University of Sydney and Sydney Local Health District, Glebe, NSW, Australia.
28
Allergist, La Rochelle, France.
29
Centre Hospitalier Valenciennes, Valenciennes, France.
30
Chief of the University Pneumology Unit- AOU Molinette, Hospital City of Health and Science of Torino, Torino, Italy.
31
Pharmacist of COFASER - Consorzio Farmacie Servizi-Salerno, Salerno, Italy.
32
Centro Médico Zambrano Hellion, Monterrey, Mexico.
33
Service de pneumologie, CHU et université d'Auvergne, Clermont-Ferrand, France.
34
Department of Respiratory Diseases, Montpellier University Hospital, Montpellier, France.
35
Department of Pediatrics, Medical School, Federal University of Minas Gerais, Belo Horizonte, Brazil.
36
Mayor of Sarno and President of Salerno Province, Anesthesiology Service, Sarno "Martiri del Villa Malta" Hospital, Sarno, Italy.
37
S. Allergologia, S. Medicina Interna, Hospital Vall d'Hebron, Barcelona, Spain.
38
Regional Ministry of Health of Andalusia, Seville, Spain.
39
ASA - Advanced Solutions Accelerator, Clapiers, France.
40
Celentano Pharmacy, Massa Lubrense, Italy.
41
Department of Public Health and Primary Care, Leiden University Medical Center, Leiden, The Netherlands.
42
S.O.S Allergology and Clinical Immunology, USL Toscana Centro, Prato, Italy.
43
Specialist Social Worker, Sorrento, Italy.
44
ENT Department, Medical Faculty, Eskisehir Osmangazi University, Eskisehir, Turkey.
45
Argentine Federation of Otorhinolaryngology Societies, Buenos Aires, Argentina.
46
Service de Pneumologie, UMR INSERM, UMR1087and CNR 6291, l'institut du thorax, University of Nantes, Nantes, France.
47
Department of Health, Social Services and Public Safety, Belfast, UK.
48
Fondazione Bruno Kessler (FBK), Trento, Italy.
49
Life and Health Sciences Research Institute (ICVS), School of Health Sciences, University of Minho, Braga, Portugal.
50
Alergologa, Guadalarara, Mexico.
51
FIMMG (Federazione Italiana Medici di Medicina Generale), Milan, Italy.
52
UCIBIO, REQYULTE, Faculty of Pharmacy and Competence Center on Active and Healthy Ageing of University of Porto (AgeUPNetWork), Porto, Portugal.
53
Ecole des Mines, Alès, France.
54
Vice Président de la CME - Centre Hospitalier, Valenciennes, France.
55
ProAR - Nucleo de Excelencia em Asma, Federal University of Bahia, Bahia, Brazil.
56
GARD/WHO Executive Committee and Federal University of Bahia, Bahia, Brazil.
57
Department of Pediatric, Imperial College London, London, UK.
58
Azienda Provinciale per i Servizi Sanitari di Trento (APSS-Trento), Trento, Italy.
59
Allergy Service, University Hospital of Federal University of Santa Catarina (HU-UFSC), Florianópolis, Brazil.
60
Sleep Unit, Department of Neurology, Hôpital Gui-de-Chauliac Montpellier, Inserm U1061, Montpellier, France.
61
Allergy Division, Chest Disease Department, University Hospital of Strasbourg, Strasbourg, France.
62
AQuAS, Barcelona, Spain & EUREGHA, European Regional and Local Health Association, Brussels, Belgium.
63
Department of Medicine, Surgery and Dentistry "Scuola Medica Salernitana", University of Salerno, Salerno, Italy.
64
Social Workers Coordinator, Sorrento, Italy.
65
Peercode DV, Gerdermalsen, The Netherlands.
66
Farmacie Dei Golfi Group, Massa Lubrense, Italy.
67
Department of Otolaryngology, University of Crete School of Medicine, Heraklion, Greece.
68
Medical Faculty, Vilnius University, Vilnius, Lithuania.
69
Clinic of Children's Diseases, Faculty of Medicine, Vilnius University, Vilnius, Lithuania.
70
University of Aguascalientes, Chihuaha, Mexico.
71
Alergologo, Playa del Carmen, Mexico.
72
Andalusian Agency for Healthcare Quality, Seville, Spain.
73
Department of Otorhinolaryngology, Academic Medical Centre, Amsterdam, The Netherlands.
74
Center for Health Technology and Services Research- CINTESIS, Faculdade de Medicina, Universidade do Porto, Porto, Portugal.
75
Allergy Unit, CUF Porto Instituto & Hospital, Porto, Portugal.
76
Allergist, Reims, France.
77
Regional Hospital of ISSSTE, Puebla, Mexico.
78
Alergologo, Guadalarara, Mexico.
79
Allergy Clinic, National Institute of Respiratory Diseases, Mexico City, Mexico.
80
Department of Pulmonary Diseases, Cerrahpasa Faculty of Medicine, Istanbul University, Istanbul, Turkey.
81
Department of Internal Medicine, Section of Allergology, Erasmus MC, Rotterdam, The Netherlands.
82
Member of the Brazilian Society of Pediatrics and Society of Immunization, Representative of GINA (Global Initiative Against Asthma), Brasilia, Brazil.
83
Allergy Clinic, Hospital Regional del ISSSTE 'Lic. López Mateos', Mexico City, Mexico.
84
Institute of Health Policy and Management iBMG, Erasmus University, Rotterdam, The Netherlands.
85
University Hospital Olomouc - National eHealth Centre, Olomouk, Czech Republic.
86
Skin and Allergy Hospital, Helsinki University Hospital, Helsinki, Finland.
87
Centich: centre d'expertise national des technologies de l'information et de la communication pour l'autonomie, Gérontopôle autonomie longévité des Pays de la Loire, Conseil régional des Pays de la Loire, Centre d'expertise Partenariat Européen d'Innovation pour un vieillissement actif et en bonne santé, Nantes, France.
88
Laboratory of Clinical Immunology, Department of Microbiology and Immunology, KU Leuven, Leuven, Belgium.
89
Alergologo, Ensenada, Mexico.
90
Division for Health Innovation, Campania Region and Federico II University Hospital Naples (R&D and DISMET), Naples, Italy.
91
Servicio de Alergia e Immunologia, Clinica Santa Isabel, Buenos Aires, Argentina.
92
Libra Foundation, Buenos Aires, Argentina.
93
Department of Respiratory Medicine, Ghent University Hospital, Ghent, Belgium.
94
Allergology Department, Centre de l'Asthme et des Allergies, Hôpital d'Enfants Armand-Trousseau (APHP, Paris), Paris, France.
95
Sorbonne Universités, UPMC Univ Paris 06, UMR_S 1136, Institut Pierre Louis d'Epidémiologie et de Santé Publique, Equipe EPAR, Paris, France.
96
Pediatric Allergy and Asthma Unit, Hacettepe University School of Medicine, Ankara, Turkey.
97
Immunology and Allergy Division, Department of Chest Diseases, School of Medicine, Hacettepe University, Ankara, Turkey.
98
Allergy Centre, Tampere University Hospital, Tampere, Finland.
99
Institute of Social Medicine, Epidemiology and Health Economics, Charité - Universitätsmedizin Berlin, Berlin, and Institute for Clinical Epidemiology and Biometry, University of Wuerzburg, Wuerzburg, Germany.
100
GARD, Geneva, Switzerland.
101
Center for Rhinology and Allergology, Wiesbaden, Germany.
102
Department of Clinical Science and Education, Södersjukhuset, Karolinska Institutet, Stockholm, Sweden.
103
Clinic of Infectious, Chest Diseases, Dermatology and Allergology, Vilnius University, Vilnius, Lithuania.
104
Department of Respiratory Medicine, Faculty of Medicine and Dentistry, University Hospital, Olomouc, Czech Republic.
105
Department of Prevention of Environmental Hazards and Allergology, Medical University of Warsaw, Warsaw, Poland.
106
Institute of Biomedicine and Molecular Immunology (IBIM), National Research Council (CNR), Palermo, Italy.
107
Clínica de Alergia, Asma y Pediatría, Hospital Médica Sur, México City, Mexico.
108
Presidente CMMC, Milano, Italy.
109
Head of the Allergy Department of Pedro de Elizalde Children's Hospital, Buenos Aires, Argentina.
110
Faculdade de Medicina da Universidade Federal da Bahia, Salvador de Bahia, Brazil.
111
Sifmed, Milano, Italy.
112
Promotor B3 Action GRoup EIP on AHA and Senior Fellow, International Foundation for Integreted Care, Aberystwyth, UK.
113
Tech Life Valley, Diepenbeek, Belgium.
114
Department of Pulmonary Medicine, CHU Sart-Tilman, Liege, Belgium.
115
University of Guadalajara, Guadalara, Mexico.
116
Faculty of Medicine, Institute of Biomedical Imaging and Life Sciences (IBILI), University of Coimbra, Coimbra, Portugal.
117
Ageing@Coimbra EIP-AHA Reference Site, Coimbra, Portugal.
118
Argentine Association of Allergy and Clinical Immunology, Buenos Aires, Argentina.
119
Hospital Regional Siglo XXI, Mexico City, Mexico.
120
Alergologo, Veracruz, Mexico.
121
Sachs' Children and Youth Hospital, Södersjukhuset, Stockholm and Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.
122
CIRFF, Federico II University, Naples, Italy.
123
Caisse d'assurance retraite et de la santé au travail du Languedoc-Roussillon (CARSAT-LR), Montpellier, France.
124
Regione Piemonte, Torino, Italy.
125
Allergy and Clinical Immunology Department, Hospital CUF-Descobertas, Lisboa, Portugal.
126
Institute of Medical Statistics, Informatics and Epidemiology, Medical Faculty, University of Cologne, Cologne, Germany.
127
Laboratory of General Pathology, Faculty of Medicine, University of Coimbra, Coimbra, Portugal.
128
Institute of Biomedical Imaging and Life Sciences (IBILI), Faculty of Medicine, University of Coimbra, Coimbra, Portugal.
129
Clinical & Experimental Respiratory Immunoallergy, ENT Department, Hospital Clínic, IDIBAPS, Universitat de Barcelona, Barcelona, Spain.
130
Department of Women and Child Health, Food Allergy Referral Centre Veneto Region, Padua General University Hospital, Padua, Italy.
131
MedScript Ltd, Dundalk, Co. Louth, Ireland.
132
Consortium of Pharmacies and Services COSAFER, Salerno, Italy.
133
Head of Respiratory Medicine, Alassia Children's Hospital, Center for Allergy and Immunology, Santa Fe, Argentina.
134
Department of Allergy, Immunology and Respiratory Medicine, Alfred Hospital and Central Clinical School, Monash University, Melbourne, Vic., Australia.
135
EFA European Federation of Allergy and Airways Diseases Patients' Associations, Brussels, Belgium.
136
Center for Pediatrics and Child Health, Institute of Human Development, Royal Manchester Children's Hospital, University of Manchester, Manchester, UK.
137
Allergy Department, 2nd Pediatric Clinic, Athens General Children's Hospital "P&A Kyriakou", University of Athens, Athens, Greece.
138
Allergy and Respiratory Diseases, IRCCS San Martino Hospital-IST-University of Genoa, Genoa, Italy.
139
Department of Pneumology, CHU Grenoble, Grenoble, France.
140
Allergy Unit, CUF-Porto Hospital and Institute, Center for Research in Health Technologies and Information Systems, CINTESIS, Universidade do Porto, Porto, Portugal.
141
Sociologist, Municipality, Sorrento, Italy.
142
Department of Otorhinolaryngology, Head and Neck Surgery, Universitätsmedizin Mannheim, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
143
Vice-Presidente of IML, Milano, Italy.
144
Alergista, Recife, Brazil.
145
Centre of Pneumology, Coimbra University Hospital, Coimbra, Portugal.
146
Alergologo, Mexico City, Mexico.
147
Medical University of Graz, Graz, Austria.
148
Allergy Unit, Presidio Columbus, Rome, Catholic University of Sacred Heart, Rome, Italy.
149
IRCCS Oasi Maria S.S., Troina, Italy.
150
Association of Finnish Pharmacists, Helsinki, Finland.
151
Allergist, Vitoria, Brazil.
152
Departement of Internal Medicine, University Hospital, Olomouc, Czech Republic.
153
IML (Lombardy Medical Initiative), Bergamo, Italy.
154
Pulmonary Division, Heart Institute (InCor), Hospital da Clinicas da Faculdade de Medicina da Universidade de Sao Paulo, Sao Paulo, Brazil.
155
Center for Life Course Health Research, Helsinki University Hospital, Helsinki University, University of Oulu, Oulu, Finland.
156
Public Health Institute of Vilnius University, Vilnius, Lithuania.
157
Imunoalergologia, Centro Hospitalar Universitário de Coimbra and Faculty of Medicine, University of Coimbra, Coimbra, Portugal.
158
Department of ENT, Medical University of Graz, Graz, Austria.
159
Division on Pharmacy and Devices Policy, Campania Region, Naples, Italy.
160
Pneumology and Allergy Department, Hospital Clínic, Clinical & Experimental Respiratory Immunoallergy, IDIBAPS, CIBERES, University of Barcelona, Barcelona, Spain.
161
Department of Lung Diseases and Clinical Allergology, University of Turku, Turku, Finland.
162
Allergy Clinic, Terveystalo, Turku, Finland.
163
Vilnius University Clinic of Children's Diseases and Public Health Institute, Vilnius, Lithuania.
164
European Academy of Paediatrics (EAP/UEMS-SP), Brussels, Belgium.
165
FILHA, Finnish Lung Association, Helsinki, Finland.
166
Unit of Geriatric Immunoallergology, University of Bari Medical School, Bari, Italy.
167
International Primary Care Respiratory Group IPCRG, Aberdeen, UK.
168
Department of Otorhinolaryngology, HNO-Klinik, Universitätsklinikum Düsseldorf, Düsseldorf, Germany.
169
EIP on AHA Coordinator, Region of Southern Denmark, Odense, Denmark.
170
Department of Medicine Solna, Immunology and Allergy Unit, Karolinska Institutet and Department of ENT Diseases, Karolinska University Hospital, Stockholm, Sweden.
171
Queen's University, Belfast, UK.
172
Celal Bayar University Department of Pulmonology, GARD Executive Committee, Manisa, Turkey.
173
Universidad Católica de Córdoba, Córdoba, Argentina.
174
Gesundheitsregion KölnBonn - HRCB Projekt GmbH, Kohln, Germany.
175
EC-CNECT-H2, European Commission, Brussels, Belgium.

Abstract

The overarching goals of the European Innovation Partnership on Active and Healthy Ageing (EIP on AHA) are to enable European citizens to lead healthy, active and independent lives whilst ageing. The EIP on AHA includes 74 Reference Sites. The aim of this study was to transfer innovation from an app developed by the MACVIA-France EIP on AHA reference site (Allergy Diary) to other reference sites. The phenotypic characteristics of rhinitis and asthma multimorbidity in adults and the elderly will be compared using validated information and communication technology (ICT) tools (i.e. the Allergy Diary and CARAT: Control of Allergic Rhinitis and Asthma Test) in 22 Reference Sites or regions across Europe. This will improve the understanding, assessment of burden, diagnosis and management of rhinitis in the elderly by comparison with an adult population. Specific objectives will be: (i) to assess the percentage of adults and elderly who are able to use the Allergy Diary, (ii) to study the phenotypic characteristics and treatment over a 1-year period of rhinitis and asthma multimorbidity at baseline (cross-sectional study) and (iii) to follow-up using visual analogue scale (VAS). This part of the study may provide some insight into the differences between the elderly and adults in terms of response to treatment and practice. Finally (iv) work productivity will be examined in adults.

KEYWORDS:

Allergy Diary ; Allergy; European Innovation Partnership on Active and Healthy Ageing; asthma; rhinitis

PMID:
28600902
DOI:
10.1111/all.13218
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for Wiley Icon for Spiral, Imperial College Digital Repository
Loading ...
Support Center